Clinical Trials
693 trialsESME-MBC
UNICANCER
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Oncoplastic Surgery Outcomes Database
Tufts Medical Center
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Wake Forest University Health Sciences
QT-RIBRATING
CMC Ambroise Paré
REBECCA
AstraZeneca
PG2 BEAM-S
E-DA Hospital
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
National Institutes of Health Clinical Center (CC)
Risk Communication Within Mexican-American Families
National Institutes of Health Clinical Center (CC)
BRCA Mutations in Latinas
National Institutes of Health Clinical Center (CC)
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
HEROIC
Sun Yat-sen University
RUGCC-BC
Rutgers, The State University of New Jersey
ELEGANCE
Novartis
NodeSMART
University Hospitals of Derby and Burton NHS Foundation Trust
Via Shalva
University Hospital, Basel, Switzerland
BCRL-SSR
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
ARTEMIS
Institut Cancerologie de l'Ouest
IMOGEN
Perspectum
Multi-center MRD Registry for Inflammatory Breast Cancer
M.D. Anderson Cancer Center
BEYOND
AstraZeneca
Non-Contrast Breast MRI Diagnosis and Risk Stratification Using DWI-Generated Synthetic Contrast Enhancement
Peking University People's Hospital
LEARN
University of Sydney
Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer
Hacettepe University
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
AstraZeneca
MACRONAC
University Hospital, Basel, Switzerland
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Asan Medical Center
Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
Memorial Sloan Kettering Cancer Center
OvAR-Y
Washington University School of Medicine
reaINAVO
Hoffmann-La Roche
HER2-positive Metastatic Breast Cancer in Kazakhstan
AstraZeneca
EXPRESSO
IRCCS San Raffaele
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Mayo Clinic
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
ERA
AstraZeneca
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
PINK
SpotitEarly
Beyond BCY
Jules Bordet Institute
Johns Hopkins Breast Cancer Program Longitudinal Repository
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mammo'C
University Hospital, Montpellier
Fluorocholine PET/MR in Breast Cancer
Taipei Veterans General Hospital, Taiwan
Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
C-BREAST-01
Gazi University
Core Biopsies for Establishing a Breast Tumor Tissue Repository
University of Southern California
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
HER2 CR
Nagoya City University